Microbial Transformation of Isosteviol and Inhibitory Effects on Epstein-Barr Virus Activation of the Transformation Products

Journal of Natural Products

Volumn 67, Issue 3, 2004, Pages 407-410

  Akihisa, Toshihiro ^a   Hamasaki, Yusuke ^a   Tokuda, Harukuni ^b   Ukiya, Motohiko ^a   Kimura, Yumiko ^a   Nishino, Hoyoku ^b  

^a NIHON UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYISOSTEVIOL; 12BETA HYDROXYISOSTEVIOL; 17 HYDROXYISOSTEVIOL; 7 OXOISOSTEVIOL; 7BETA HYDROXYISOSTEVIOL; DITERPENE; DITERPENOID; EARLY ANTIGEN; ISOSTEVIOL; PHORBOL 13 ACETATE 12 MYRISTATE; STEVIOSIDE; TUMOR PROMOTER; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BIOTRANSFORMATION; CANCER INHIBITION; DRUG POTENCY; EPSTEIN BARR VIRUS; FUNGUS; GLOMERELLA CINGULATA; HUMAN; HUMAN CELL; HYDROLYSIS; METABOLITE; MICROBIAL METABOLISM; MORTIERELLA; MORTIERELLA ELONGATE; NONHUMAN; RAJI CELL; VIRUS ACTIVATION;

ANTIGENS, VIRAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOTRANSFORMATION; DITERPENES; DITERPENES, KAURANE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSIDES; HERPESVIRUS 4, HUMAN; HUMANS; MORTIERELLA; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; VIRUS ACTIVATION;

ASPERGILLUS; ASPERGILLUS NIGER; CINGULATA; FUNGI; GLOMERELLA; GLOMERELLA CINGULATA; HUMAN HERPESVIRUS 4; MORTIERELLA;

EID: 1642424286     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np030393q     Document Type: Article

References (20)

1. Soejarto, D. D.; Kinghorn, A. D.; Farnsworth, N. R. J. Nat. Prod. 1982, 45, 590-599.
2. Nanayakkara, N. P. D.; Kloke, J. A.; Compadre, C. M.; Hussain, P. A.; Pezzuto, J. M.; Kinghorn, A. D. J. Nat. Prod. 1987, 50, 434-441.
3. Bracht, A. K.; Alvarez, M.; Bracht, A. Biochem. Pharmacol. 1985, 34, 873-882.
4. Yamamoto, N. S.; Kelmer Bracht, A. M.; Ishii, E. L.; Kemmelmeier, F. S.; Alvarez, M.; Bracht, A. Experientia 1985, 41, 55-57.
5. Ishii, E. L.; Schwab, A. J.; Bracht, A. Biochem. Pharmacol. 1987, 36, 1417-1433.
6. Atta-ur-Rahman; Farooq, A.; Anjum, S.; Choudhary, M. I. Curr. Med. Chem. 1999, 3, 309-326.
7. Bearder, J. R.; Frydman, V. M.; Gaskin, P.; MacMillan, J.; Wels, C. M.; Phinney, B. O. J. Chem. Soc., Perkin Trans. 1 1976, 173-183.
8. de Oliveira, B. H.; Strapasson, R. A. Phytochemistry 1996, 43, 393-395.
9. de Oliveira, B. H.; dos Santos, M. C.; Leal, P. C. Phytochemistry 1999, 51, 737-741.
10. Hsu, F.-L.; Hou, C.-C.; Yahng, L.-M.; Cheng, J.-T.; Chi, T.-Ch.; Liu, P.-C.; Lin, S.-J. J. Nat. Prod. 2002, 65, 273-277.
11. Akihisa, T.; Yasukawa, K. In Studies in Natural Products Chemistry, Vol. 25, Bioactive Natural Products (Part F); Atta-ur-Rahman, Ed.; Elsevier Science B.V.: Amsterdam, 2001; pp 43-87.
12. Akihisa, T.; Takamine, Y.; Yoshizumi, K.; Tokuda, H.; Kimura, Y.; Ukiya, M.; Nakahara, T.; Yokochi, T.; Ichiishi, E.; Nishino, H. J. Nat. Prod. 2002, 65, 278-282.
13. Avent, A. G.; Hanson, J. R.; de Oliveira, B. H. Phytochemistry 1990, 29, 2712-2715.
14. Avent, A. G.; Hanson, J. R.; Hitchcock, P. B.; de Oliveira, B. H. J. Chem. Soc., Perkin Trans. 1 1990, 2661-2665.
15. The viability percentages of Raji cells are around 80% even if the incubation (at 37 °C for 48 h) was undertaken without test compound.
16. Murakami, A.; Ohigashi, H.; Koshimizu, K. Biosci. Biotech. Biochem. 1999, 60, 1-8.
17. Van Calsteren, M.-R.; Bussière, Y.; Bissonnette, M. C. Spectroscopy 1993, 11, 143-156.
18. Ishikawa, H.; Kitahara, S.; Ohtani, K.; Ikuhara, C.; Tanaka, O. Agric. Biol. Chem. 1990, 54, 3137-3143.
19. Compadre, C. M.; Hussain, R. A.; Nanayakkara, N. P. D.; Pezzuto, J. M.; Kinghorn, A. D. Biomed. Environ. Mass Spectrom. 1988, 15, 211-222.
20. Takaishi, Y.; Ujita, K.; Tokuda, H.; Nishino, H.; Iwashima, A.; Fujita, T. Cancer Lett. 1992, 65, 19-26.